发明名称 |
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR DOWNREGULATION OF PRO-INFLAMMATORY CYTOKINES |
摘要 |
This invention provides a method to prevent, control, and/or treat an inflammatory disease or disorder by administering at least one agonist of guanalyte cyclase receptor, or pharmaceutical compositions thereof, either alone or either concurrently or sequentially with another compound or an active agent used to treat the disease or disorder, and/or with an inhibitor of cGMP-dependent phosphodieasterases. |
申请公布号 |
US2016235807(A1) |
申请公布日期 |
2016.08.18 |
申请号 |
US201415026560 |
申请日期 |
2014.10.09 |
申请人 |
SYNERGY PHARMACEUTICALS, INC. |
发明人 |
SHAILUBHAI Kunwar |
分类号 |
A61K38/10;A61K9/00;A61K45/06;A61K31/40;A61K31/5377 |
主分类号 |
A61K38/10 |
代理机构 |
|
代理人 |
|
主权项 |
1. A composition comprising a guanylate cyclase receptor agonist (GCRA) peptide comprising of the sequence of any one of Tables 1-7 and a NF-κB inhibitor, a c-Src tyrosine kinase inhibitor, a 5-ASA agent, a c-Myc inhibitor, or an Ikk inhibitor. |
地址 |
New York NY US |